首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1733259

按藥品類型、產品類型和地區分類的網路藥局市場（2026-2032 年）

E Pharmacy Market By Drug Type (Prescription Drugs, Over the Counter Drugs), Product Type (Skin Care, Dental, Cold, Flu, Vitamins) & Region for 2026-2032

出版日期: 2025年04月30日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

網路藥局市場評估（2026-2032）

智慧型手機和網路連線的普及使得更多人可以更方便地在線購買藥品，讓顧客可以在自己舒適的家中方便地獲得處方箋和非處方藥。其次，新冠疫情推動醫療服務數位化不斷提升，遠端醫療和線上問診越來越被廣泛接受，將推動網路藥局服務需求在 2024 年超過 809.6 億美元，並在 2032 年達到 2,425.4 億美元。

對個人化醫療和藥物管理的日益關注正在推動網路藥局交付的創新，例如提供客製化的藥物提醒和健康監測工具，從而在競爭日益激烈的市場中提高客戶滿意度和忠誠度，預計從 2026 年到 2032 年的複合年成長率約為 14.70%。

網路藥局市場定義/概述

網路藥局網路藥局是透過網路平台在線銷售和分銷藥品和健康相關產品。這項策略使顧客可以在自己舒適的家中輕鬆獲得處方藥和非處方藥、保健品和個人保健產品。網路藥局應用包括線上處方箋續藥、遠端醫療諮詢、健康監測服務以及直接向客戶送藥。網路藥局的未來是樂觀的，數位健康技術的進步、網際網路接入的增加以及對高效醫療保健解決方案的需求不斷成長預計將推動其發展。隨著藥品網上銷售規則的訂定以及消費者對電子健康益處的認知不斷提高，網路藥局業務將迅速擴張，提供更個人化的服務和更好的客戶體驗。

對個人化醫療的日益重視是否會推動網路藥局市場的發展？

隨著對個人化醫療的日益關注，網路藥局產業預計將大幅成長。隨著科技的進步，網路藥局正在利用數據分析和人工智慧提供個人化的藥物和健康建議，提高患者的參與度和幸福感。 2023 年 9 月，遠端醫療平台 Teladoc Health 宣布啟動一項新的個人化醫療計劃，旨在根據獨特的患者資料加強治療計劃。此舉反映了業界朝著個人化醫療發展的更廣泛趨勢，並表明網路藥局能夠很好地滿足客製化健康解決方案的需求。

例如，2023年7月，美國食品藥物管理局（FDA）發布指南，鼓勵使用數位健康技術支援個人化醫療，強調將此類方法納入現有醫療保健系統的必要性。根據 Verified Market Research 的預測，由於個人化醫療服務需求的不斷成長，網路藥局市場將在 2024 年至 2032 年期間以 14.70% 的複合年成長率發展。隨著消費者對個人化醫療保健解決方案的需求，技術創新與正確的法律體制的結合將有助於網路藥局產業的發展。

藥品銷售監管日益嚴格是否會阻礙網路藥局市場的成長？

藥品銷售法規的日益增加可能會阻礙網路藥局業務的擴張，因為遵守各種法律將成為網路藥局面臨的主要障礙。許多國家的監管機構都制定了嚴格的標準來確保藥品安全，包括許可、藥品品質監控和保護病患隱私。網路藥局必須管理這些複雜的規定，這會增加營運成本和管理麻煩。小型企業尤其可能難以達到這些標準，導致市場競爭和創新減少。此外，違規的風險可能會阻礙新進入網路藥局市場的參與企業，從而限制其整體成長前景。

雖然嚴格的規定可能是一個障礙，但它們也有助於提高客戶的信任和安全，這可能對長期的市場成長產生積極的影響。有了更完善的法律規範，消費者可能會更有信心在網路上訂購藥品，從而增加對信譽良好的網路藥局服務的需求。在這種環境下，成功遵守法規的網路藥局有可能透過提高聲譽和信譽來實現差異化並增加市場佔有率。最終，加強監管對網路藥局業務的影響將取決於公司在維持用戶參與和服務品質的同時如何適應合規需求。

The growing use of smartphones and internet connectivity has made online medication shopping more accessible to a wider audience, allowing customers to conveniently obtain prescriptions and over-the-counter drugs from the comfort of their own homes. Second, the ongoing digitization of healthcare services, spurred by the COVID-19 pandemic, has led to a wider acceptance of telehealth and online consultations, increasing demand for e-pharmacy services is surpassing USD 80.96 Billion in 2024 and reaching USD 242.54 Billion by 2032.

The growing emphasis on personalized healthcare and medication management has prompted e-pharmacies to innovate their service offerings, such as providing customized medication reminders and health monitoring tools, thereby increasing customer satisfaction and loyalty in an increasingly competitive market is expected to grow at a CAGR of about 14.70% from 2026 to 2032.

E Pharmacy Market: Definition/ Overview

E-pharmacy, or electronic pharmacy, is the online selling and distribution of pharmaceuticals and health-related items via internet-based platforms. This strategy enables customers to easily obtain prescription and over-the-counter pharmaceuticals, health supplements, and personal care products from the comfort of their own homes. E-pharmacy applications include online prescription refills, telemedicine consultations, health monitoring services, and direct pharmaceutical delivery to customers. The future of e-pharmacy seems optimistic, with development expected to be driven by advances in digital health technologies, increased internet access, and rising demand for efficient healthcare solutions. As rules adapt to allow online pharmaceutical sales and consumer awareness of e-health benefits grows, the e-pharmacy business is likely to increase rapidly, providing more personalized services and improved customer experiences.

Will Growing Emphasis on Personalized Healthcare Drive the E Pharmacy Market?

The growing emphasis on personalized healthcare is expected to fuel significant growth in the e-pharmacy industry, as customers seek tailored solutions to meet their individual health demands. With technological improvements, e-pharmacies are using data analytics and artificial intelligence to give personalized drug regimens and health recommendations, hence increasing patient engagement and happiness. In September 2023, Teladoc Health, a telehealth platform, announced the introduction of a new personalized medicine project aiming at enhancing treatment plans based on unique patient profiles. This move mirrors a broader industry trend toward personalized healthcare, implying that e-pharmacies are well-positioned to address the demand for customized health solutions.

For instance, in July 2023, the US Food and Drug Administration (FDA) issued guidelines encouraging the use of digital health technologies to support personalized medicine, highlighting the necessity of incorporating these approaches into existing healthcare systems. According to Verified Market Research, the e-pharmacy market will develop at a CAGR of 14.70% between 2024 and 2032, driven by increased demand for individualized healthcare services. This convergence of technical innovation and appropriate legal frameworks sets the e-pharmacy sector for growth as consumers desire personalized healthcare solutions.

Will Growing Regulations Regarding the Sale of Pharmaceuticals Hamper the Growth of the E Pharmacy Market?

Growing rules governing the selling of medications may stymie the expansion of the e-pharmacy business, as complying with various laws creates substantial obstacles for online pharmacies. Many countries' regulatory agencies have created severe criteria to assure medicine safety, such as licensing verification, drug quality monitoring, and patient privacy protection. E-pharmacies must manage these complex rules, which can raise operating costs and administrative hassles. Smaller companies, in particular, may struggle to fulfill these criteria, resulting in less competition and innovation in the market. Furthermore, the risk of non-compliance can dissuade new participants from entering the e-pharmacy market, restricting overall growth prospects.

While strict rules may provide obstacles, they also help to increase customer trust and safety, which could have a positive impact on long-term market growth. As regulatory frameworks become more established, consumers may gain confidence in ordering pharmaceuticals online, increasing demand for reputable e-pharmacy services. In this environment, e-pharmacies that successfully comply with rules may distinguish themselves through increased reputation and reliability, potentially acquiring a larger share of the market. Finally, the impact of increased restrictions on the e-pharmacy business will be determined by how well enterprises adapt to compliance needs while preserving user engagement and service quality.

Category-Wise Acumens

Will Rising Demand of Prescription Drugs Propel the E Pharmacy Market?

The increasing demand for prescription pharmaceuticals is expected to considerably boost the growth of the e-pharmacy industry, owing to factors such as increased chronic disease prevalence and the convenience of online ordering. As more patients require continuing medicine for ailments such as diabetes, hypertension, and mental health difficulties, e-pharmacies are well-positioned to address this growing demand by giving convenient access to important drugs. For instance, in September 2023, CVS Health declared a strategic focus on increasing its digital health services, highlighting the necessity of online prescriptions to improve patient access and drug management. This move highlights the synchronization of traditional pharmacy operations with consumers' changing requirements, demonstrating how established enterprises are shifting to capitalize on the e-pharmacy boom.

Furthermore, government initiatives promoting telehealth and digital healthcare solutions boost the e-pharmacy market's growth prospects. For instance, in April 2023, the United States Department of Health and Human Services (HHS) issued new guidelines to make telehealth services, such as online prescription refills, more accessible, particularly for mental health and substance use issues. These regulations aim to increase healthcare access for marginalized groups, which will have a direct influence on the e-pharmacy business by encouraging more patients to use online services for their prescriptions.

In contrast, the over-the-counter (OTC) pharmaceuticals segment is the fastest-growing category, driven by rising consumer awareness of health and wellness, as well as the convenience of ordering OTC meds online. The growing tendency of self-medication, particularly among younger consumers who prefer the convenience of online purchase, is driving this segment's expansion.

Will Rising Cases of Cold and Flu Drive the Growth of E Pharmacy Market?

The rising number of cold and flu cases is expected to generate significant growth in the e-pharmacy market, as more consumers seek easy and rapid access to over-the-counter pharmaceuticals and health items online. With a growing occurrence of respiratory illnesses, particularly during seasonal peaks, e-pharmacies are becoming a popular choice for those who want to treat their symptoms without having to visit a real pharmacy. In October 2023, Walgreens reported an increase in online sales of cold and flu treatments, reflecting consumer preferences toward seeking fast relief via digital platforms. The convenience of online buying, especially during illness when going out may be less tempting, allows e-pharmacies to grab a higher market share in this area.

For instance, in September 2023, the Centers for Disease Control and Prevention (CDC) initiated a campaign advocating vaccination and early treatment of flu symptoms, resulting in increased consumer demand for cold and flu treatments. The emphasis on accessibility and quick reaction to disease is well aligned with the ability of e-pharmacies to deliver health supplies directly to consumers' homes.

However, the skin care area is emerging as the fastest-growing category, owing to increased consumer interest in personal wellbeing, cosmetic products, and preventative healthcare. With the rise of social media and online beauty trends, more people are turning to e-pharmacies for skincare solutions, which include both medicinal and cosmetic items. This shift toward skin health and wellbeing reflects a substantial change in consumer behavior, setting the skin care category for strong growth in the e-pharmacy market.

Country/Region-wise

Will Widespread Internet Penetration in North America Drive the E Pharmacy Market?

The high internet access in North America is a major driver of the e-pharmacy sector. As of 2023, the Internet and Mobile Association of North America claimed that internet penetration in the region had reached 94.6%, with 392 million people routinely accessing online services. This high level of connection has made the environment ideal for the growth of e-pharmacy services. In February 2024, the Federal Communications Commission (FCC) revealed that 99% of Americans now have broadband internet connection, up from 93.5% in 2020. This enhanced accessibility has enabled more consumers to use online pharmacy services, particularly in rural areas where physical pharmacies are less accessible. The ease of obtaining prescriptions online, together with the opportunity to readily compare prices and access health information, has led to a surge in e-pharmacy adoption.

In March 2024, Amazon Pharmacy reported a 45% year-over-year rise in prescription orders, citing greater internet access and shifting consumer preferences. Similarly, CVS Health said in January 2024 that their digital pharmacy revenues had increased by 38% over the previous year, accounting for 25% of all prescription fills. On the regulatory front, the U.S. Food and Drug Administration (FDA) published new rules in September 2023 to make it easier for e-pharmacies to obtain licenses in several states, with the goal of facilitating the growth of online pharmacy services. A poll done by the National Association of Boards of Pharmacy in July 2023 indicated that 62% of North American customers have used an online pharmacy service at least once in the previous year.

Will Rising Demand for Convenient Access to Medications in Asia-Pacific Propel the E Pharmacy Market?

The Asia-Pacific region's increased desire for convenient drug access is expected to considerably accelerate the e-pharmacy industry, led by a growing population that is increasingly reliant on digital healthcare solutions. As more consumers in this region adopt online shopping and mobile applications, the e-pharmacy sector stands to benefit from the desire for convenient access to both prescription and over-the-counter drugs. For instance, in August 2023, India-based e-pharmacy PharmEasy reported a 60% growth in online medication orders, owing to a growing preference for home delivery. This trend demonstrates the region's shift toward digital healthcare solutions, as well as how convenience influences customer behavior.

Furthermore, government initiatives in the Asia-Pacific region are boosting the e-pharmacy market's growth prospects. In June 2023, the Chinese government issued new policies to promote the digitalization of healthcare services, including online pharmaceutical sales, with the goal of improving access for rural communities.

Competitive Landscaped

The competitive landscape of the e-pharmacy market is characterized by a dynamic interplay of established pharmacy chains, technology-driven startups, and online healthcare service providers. This market features a mix of local and global players, each vying for a share through innovative services, competitive pricing, and extensive product offerings. Companies are increasingly focusing on enhancing customer experience through user-friendly mobile apps and websites, along with personalized services such as telehealth consultations and medication reminders. Additionally, strategic partnerships and collaborations with healthcare providers and technology firms are becoming common as e-pharmacies seek to expand their reach and improve service delivery. Regulatory compliance and maintaining quality standards are also critical factors that influence competitive positioning in this rapidly evolving sector.

Some of the prominent players operating in the E pharmacy market include:

CVS Health Corporation

DocMorris

Express Scripts Holding Company

Giant Eagle,

Optum Rx,

Rowlands Pharmacy

The Kroger Co.

Walgreen Co.

Walmart Stores,

Latest Developments

In August 2023, Walgreens announced the development of its digital health services, with an emphasis on improving its e-pharmacy platform. In response to the increased demand for online healthcare solutions, the firm plans to improve the user experience with an upgraded mobile app that makes prescription refills and medication monitoring easier.

In September 2023, India-based e-pharmacy PharmEasy announced a strategic agreement with local healthcare providers to deliver individualized drug management services. This alliance seeks to improve patient participation and ensure timely delivery of critical medications, reflecting the growing emphasis on individualized healthcare solutions.

1 INTRODUCTION OF GLOBAL E Pharmacy MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL E Pharmacy MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL E Pharmacy MARKET, BY DRUG TYPE

5.1 Overview
5.2 Prescription Drugs
5.3 Over-the-counter (OTC) Drugs

6 GLOBAL E Pharmacy MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Skin Care
6.3 Dental
6.4 Cold and Flu
6.5 Vitamins
6.6 Others

7 GLOBAL E Pharmacy MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5. Rest of the World
- 7.5.1. Latin America
- 7.5.2. Middle East & Africa

8 GLOBAL E Pharmacy MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market ranking
8.3 Vendor Landscape
8.4 Key Development Strategies

9 COMPANY PROFILES

9.1 CVS Health Corporation
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 DocMorris
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Express Scripts Holding Company
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Giant Eagle Inc.
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Optum Rx Inc.
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Rowlands Pharmacy
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 The Kroger Co.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Walgreen Co.
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Walmart Stores Inc
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments